Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PhRMA Plan For Rx-Only Medicare Bill Calls For Independence From HCFA

Executive Summary

The White House may be willing to support a Medicare drug benefit that is overseen by an agency other than the Health Care Financing Administration, Pharmaceutical Research & Manufacturers of America President Alan Holmer maintained.

You may also be interested in...

Medicare Reform Proposals For Debate In 2000

With Congress returning from recess Jan. 24, approaches to reforming Medicare will grow in importance as an election-year political issue. Announced reform proposals are listed below

Glaxo SmithKline U.S. Marketing Could Reach 250,000 MDs In One Week

The combined Glaxo SmithKline U.S. sales force would be able to call on 250,000 physicians during the first week of a major product launch, the companies told a Jan. 17 London press briefing on their proposed merger.

PhRMA Moves To Head Off Clinton Assault; Considers Incremental Rx Benefit

The Pharmaceutical Research & Manufacturers of America is attempting to defuse some of the Clinton Administration's rhetoric on drug costs to the elderly ahead of the State of the Union address.

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts